广谱保守致病性大肠杆菌抗原SslE经黏膜-胃肠外混合免疫可诱导强效黏膜与全身免疫且不影响小鼠肠道菌群
本研究针对广泛分布于肠内致病性大肠杆菌(InPEC)和肠外致病性大肠杆菌(ExPEC)的保守抗原SslE,在小鼠中比较了不同免疫策略的T细胞和抗体应答。结果显示,鼻内初免加两次肌内加强的混合免疫方案诱导的总体免疫应答优于单独鼻内或单独肌内方案,且该方案未影响小鼠肠道菌群丰富度,SslE免疫组与PBS组盲肠微生物组成相当。
要点
- 鼻内初免加两次肌内加强的SslE混合免疫方案诱导的免疫应答优于单途径方案。
- 该混合免疫方案未改变小鼠肠道菌群丰富度,盲肠微生物组成与PBS组相当。
- SslE广泛分布于InPEC和ExPEC,可作为广谱大肠杆菌疫苗候选抗原。
核心结论
- SslE经鼻内初免加两次肌内加强的混合免疫可增强总体免疫应答,且不扰动小鼠肠道菌群,支持其用于未来同时靶向InPEC和ExPEC的疫苗接种策略。
研究设计与样本
- 小鼠免疫原性研究,比较SslE经鼻内初免加两次肌内加强、单独鼻内、单独肌内三种免疫方案,分析T细胞和抗体应答,并评估肠道菌群。
主要发现
- 鼻内初免加两次肌内加强组小鼠的总体免疫应答高于单独鼻内或单独肌内方案组。
- SslE免疫组与PBS组小鼠盲肠微生物组成相当,肠道菌群丰富度未受影响。
临床怎么用
- 提示SslE混合黏膜-胃肠外免疫策略可在诱导强效黏膜和全身免疫的同时避免肠道菌群紊乱,为未来广谱大肠杆菌疫苗设计提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Emergence and dissemination of multidrug resistance among pathogenic Escherichia coli have posed a serious threat to public health across developing and developed countries. In combination with a flexible repertoire of virulence mechanisms, E. coli can cause a vast range of intestinal (InPEC) and extraintestinal (ExPEC) diseases but only a very limited number of antibiotics still remains effective against this pathogen. Hence, a broad spectrum E. coli vaccine could be a promising alternative to prevent the burden of such diseases, while offering the potential for covering against several InPEC and ExPEC at once. SslE, the Secreted and Surface-associated Lipoprotein of E. coli, is a widely distributed protein among InPEC and ExPEC. SslE functions ex vivo as a mucinase capable of degrading mucins and reaching the surface of mucus-producing epithelial cells. SslE was identified by reverse vaccinology as a protective vaccine candidate against an ExPEC murine model of sepsis, and further shown to be cross-effective against other ExPEC and InPEC models of infection. In this study, we aimed to gain insight into the immune response to antigen SslE and identify an immunization strategy suited to generate robust mucosal and systemic immune responses. We showed, by analyzing T cell and antibody responses, that mice immunized with SslE via an intranasal prime followed by two intramuscular boosts developed an enhanced overall immune response compared to either intranasal-only or intramuscular-only protocols. Importantly, we also report that this regimen of immunization did not impact the richness of the murine gut microbiota, and mice had a comparable cecal microbial composition, whether immunized with SslE or PBS. Collectively, our findings further support the use of SslE in future vaccination strategies to effectively target both InPEC and ExPEC while not perturbing the resident gut microbiota.
引用
- Naili I, Vinot J, Baudner BC, et al. Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota. Vaccine. 2018. PMID: 30503655. doi:10.1016/j.vaccine.2018.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。